Example: stock market

CLINIMIX and CLINIMIX E Injections - Baxter

CLINIMIX and CLINIMIX E InjectionsNutrient ProfileINDICATIONS CLINIMIX (amino acids in dextrose) Injections and CLINIMIX E (amino acids with electrolytes in dextrose with calcium) Injections are indicated as a source of calories and protein (and electrolytes for CLINIMIX E) for patients requiring parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated. CLINIMIX and CLINIMIX E may be used to treat negative nitrogen balance in patients. Please see Indications and Important Risk Information on inside page Please see accompanying Package Inserts for full Prescribing Information CLINIMIX E CLINIMIX (amino acids in dextrose) Injections and CLINIMIX E (amino acids with electrolytes in dextrose with calcium) Injections are indicated as a source of calories and protein (and electrolytes for CLINIMIX E) for patients requiring parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated.

syndrome. Thiamine deficiency and fluid retention may also develop. Monitor severely undernourished patients and slowly increase nutrient intakes. • CLINIMIX and CLINIMIX E solutions containing more than 5% dextrose have an osmolarity of ≥ 900 mOsm/L and must be infused through a central catheter.

Tags:

  Deficiency, Injection, Thiamine, Clinimix, Clinimix and clinimix e injections, Thiamine deficiency

Information

Domain:

Source:

Link to this page:

Please notify us if you found a problem with this document:

Other abuse

Advertisement

Transcription of CLINIMIX and CLINIMIX E Injections - Baxter

1 CLINIMIX and CLINIMIX E InjectionsNutrient ProfileINDICATIONS CLINIMIX (amino acids in dextrose) Injections and CLINIMIX E (amino acids with electrolytes in dextrose with calcium) Injections are indicated as a source of calories and protein (and electrolytes for CLINIMIX E) for patients requiring parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated. CLINIMIX and CLINIMIX E may be used to treat negative nitrogen balance in patients. Please see Indications and Important Risk Information on inside page Please see accompanying Package Inserts for full Prescribing Information CLINIMIX E CLINIMIX (amino acids in dextrose) Injections and CLINIMIX E (amino acids with electrolytes in dextrose with calcium) Injections are indicated as a source of calories and protein (and electrolytes for CLINIMIX E) for patients requiring parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated.

2 CLINIMIX and CLINIMIX E may be used to treat negative nitrogen Please see Indications and Important Risk 1 PRODUCTCLINIMIX Inj. CLINIMIX Inj. CLINIMIX Inj. CLINIMIX E E E Inj. CLINIMIX E E Volume (without lipids)1-Liter1-Liter1-Liter1-Liter1-Lit er1-Liter1-Liter1-Liter1-LiterAmino Acid Concentration5%10%15%20%5%5%10%15%20%gm Dextrose/L501001502005050100150200gm Amino Acids/L (mEq/L)--------3535353535 Potassium (mEq/L)--------3030303030 Magnesium (mEq/L)--------55555 Calcium (mEq/L) (mEq/L)373742425170708080 Chloride (mEq/L)171720203939393939 Phosphate (as HPO4=) (mmol/L)--------1515151515pH* (mOsmol/L)675930125515056658151070139516 50 Kcal from Amino Acids/L170170200200110170170200200 Kcal from Dextrose/L170340510680170170340510680 Total Kcal/L340510710880280340510710880 Total Kcal with IV Fat Emulsion added**+ 20% 500 mL (1000 Kcal) 134015101710188012801340151017101880+ 20% 250 mL (500 Kcal)840101012101380780840101012101380+ 10% 500 mL (550 Kcal)890106012601430830890106012601430+ 10% 250 mL (275 Kcal)61578598511555556157859851155 Final concentrations AFTER mixing.

3 * pH Range = ** Data on file, Baxter Healthcare (amino acids in dextrose) and CLINIMIX E amino acids with electrolytes in dextrose with calcium) Injections Nutritional ProfileNutrients per 1-Liter Container1 PRODUCTCLINIMIX Inj. CLINIMIX Inj. CLINIMIX Inj. CLINIMIX E E E Inj. CLINIMIX E E Volume (without lipids)1-Liter1-Liter1-Liter1-Liter1-Lit er1-Liter1-Liter1-Liter1-LiterAmino Acid Concentration5%10%15%20%5%5%10%15%20%gm Dextrose/L501001502005050100150200gm Amino Acids/L (mEq/L)--------3535353535 Potassium (mEq/L)--------3030303030 Magnesium (mEq/L)--------55555 Calcium (mEq/L) (mEq/L)373742425170708080 Chloride (mEq/L)171720203939393939 Phosphate (as HPO4=) (mmol/L)--------1515151515pH* (mOsmol/L)675930125515056658151070139516 50 Kcal from Amino Acids/L170170200200110170170200200 Kcal from Dextrose/L170340510680170170340510680 Total Kcal/L340510710880280340510710880 Total Kcal with IV Fat Emulsion added**+ 20% 500 mL (1000 Kcal) 134015101710188012801340151017101880+ 20% 250 mL (500 Kcal)840101012101380780840101012101380+ 10% 500 mL (550 Kcal)890106012601430830890106012601430+ 10% 250 mL (275 Kcal)

4 61578598511555556157859851155* pH Range = ** Data on file, Baxter Healthcare see accompanying Package Inserts for full Prescribing InformationCLINIMIX (amino acids in dextrose) and CLINIMIX E amino acids with electrolytes in dextrose with calcium) Injections Nutritional ProfileNutrients per 1-Liter Container1 PRODUCTCLINIMIX Inj. CLINIMIX Inj. CLINIMIX Inj. CLINIMIX E E E Inj. CLINIMIX E E Volume (without lipids)1-Liter1-Liter1-Liter1-Liter1-Lit er1-Liter1-Liter1-Liter1-LiterAmino Acid Concentration5%10%15%20%5%5%10%15%20%gm Dextrose/L501001502005050100150200gm Amino Acids/L (mEq/L)--------3535353535 Potassium (mEq/L)--------3030303030 Magnesium (mEq/L)--------55555 Calcium (mEq/L) (mEq/L)373742425170708080 Chloride (mEq/L)171720203939393939 Phosphate (as HPO4=) (mmol/L)--------1515151515pH* (mOsmol/L)675930125515056658151070139516 50 Kcal from Amino Acids/L170170200200110170170200200 Kcal from Dextrose/L170340510680170170340510680 Total Kcal/L340510710880280340510710880 Total Kcal with IV Fat Emulsion added**+ 20% 500 mL (1000 Kcal) 134015101710188012801340151017101880+ 20% 250 mL (500 Kcal)840101012101380780840101012101380+ 10% 500 mL (550 Kcal)890106012601430830890106012601430+ 10% 250 mL (275 Kcal)

5 61578598511555556157859851155 Please see accompanying Package Inserts for full Prescribing InformationCLINIMIX (amino acids in dextrose) and CLINIMIX E amino acids with electrolytes in dextrose with calcium) Injections Nutritional ProfileNutrients per 1-Liter ContainerFor more information, contact Medical Information at 1-800-422-2751 or visit Volume (without lipids)2-Liter2-Liter2-Liter2-Liter2-Lit er2-Liter2-Liter2-LiterAmino Acid Concentration5%10%15%20%5%10%15%20%gm Dextrose/2 L100200300400100200300400gm Amino Acids/2 L85851001008585100100gm Nitrogen/2 (mEq/2 L)--------70707070 Potassium (mEq/2 L)--------60606060 Magnesium (mEq/2 L)--------10101010 Calcium (mEq/2 L)--------9999 Acetate (mEq/2 L)74748484140140160160 Chloride (mEq/2 L)3434404078787878 Phosphate (as HPO4=) (mmol/2 L)--------30303030pH* (mOsmol/L)67593012551505815107013951650 Kcal from Amino Acids/2 L340340400400340340400400 Kcal from Dextrose/2 L3406801020136034068010201360 Total Kcal/2 L680102014201760680102014201760 Total Kcal with IV Fat Emulsion added**+ 20% 500 mL (1000 Kcal)16802020242027601680202024202760+ 20% 250 mL (500 Kcal)11801520192022601180152019202260+ 10% 500 mL (550 Kcal)12301570197023101230157019702310+ 10% 250 mL (275 Kcal)9551295169520359551295169520352 PRODUCTCLINIMIX E E E E (amino acids in dextrose) and CLINIMIX E amino acids with electrolytes in dextrose with calcium) Injections Nutritional ProfileNutrients per 2-Liter ContainerFinal concentrations AFTER mixing.

6 * pH Range = ** Data on file, Baxter Healthcare Volume (without lipids)2-Liter2-Liter2-Liter2-Liter2-Lit er2-Liter2-Liter2-LiterAmino Acid Concentration5%10%15%20%5%10%15%20%gm Dextrose/2 L100200300400100200300400gm Amino Acids/2 L85851001008585100100gm Nitrogen/2 (mEq/2 L)--------70707070 Potassium (mEq/2 L)--------60606060 Magnesium (mEq/2 L)--------10101010 Calcium (mEq/2 L)--------9999 Acetate (mEq/2 L)74748484140140160160 Chloride (mEq/2 L)3434404078787878 Phosphate (as HPO4=) (mmol/2 L)--------30303030pH* (mOsmol/L)67593012551505815107013951650 Kcal from Amino Acids/2 L340340400400340340400400 Kcal from Dextrose/2 L3406801020136034068010201360 Total Kcal/2 L680102014201760680102014201760 Total Kcal with IV Fat Emulsion added**+ 20% 500 mL (1000 Kcal)16802020242027601680202024202760+ 20% 250 mL (500 Kcal)11801520192022601180152019202260+ 10% 500 mL (550 Kcal)12301570197023101230157019702310+ 10% 250 mL (275 Kcal)9551295169520359551295169520352 PRODUCTCLINIMIX E E E E (amino acids in dextrose) and CLINIMIX E amino acids with electrolytes in dextrose with calcium) Injections Nutritional ProfileNutrients per 2-Liter Container* pH Range = ** Data on file, Baxter Healthcare see accompanying Package Inserts for full Prescribing InformationTotal Volume (without lipids)2-Liter2-Liter2-Liter2-Liter2-Lit er2-Liter2-Liter2-LiterAmino Acid Concentration5%10%15%20%5%10%15%20%gm Dextrose/2 L100200300400100200300400gm Amino Acids/2 L85851001008585100100gm Nitrogen/2 (mEq/2 L)--------70707070 Potassium (mEq/2 L)--------60606060 Magnesium (mEq/2 L)--------10101010 Calcium (mEq/2 L)--------9999 Acetate (mEq/2 L)74748484140140160160 Chloride (mEq/2 L)3434404078787878 Phosphate (as HPO4=) (mmol/2 L)--------30303030pH* (mOsmol/L)

7 67593012551505815107013951650 Kcal from Amino Acids/2 L340340400400340340400400 Kcal from Dextrose/2 L3406801020136034068010201360 Total Kcal/2 L680102014201760680102014201760 Total Kcal with IV Fat Emulsion added**+ 20% 500 mL (1000 Kcal)16802020242027601680202024202760+ 20% 250 mL (500 Kcal)11801520192022601180152019202260+ 10% 500 mL (550 Kcal)12301570197023101230157019702310+ 10% 250 mL (275 Kcal)9551295169520359551295169520352 PRODUCTCLINIMIX E E E E (amino acids in dextrose) and CLINIMIX E amino acids with electrolytes in dextrose with calcium) Injections Nutritional ProfileNutrients per 2-Liter ContainerPlease see accompanying Package Inserts for full Prescribing InformationTo mix solutions1 Grasp the container firmly on each side of the top of the bag (hanger end).2 Roll the bag to open seal between chambers as Mix solutions Check for IMPORTANT RISK INFORMATIONCLINIMIX and CLINIMIX E Injections are contraindicated in patients with known hypersensitivity to one or more amino acids or dextrose; in patients with inborn errors of amino acid metabolism due to risk of severe metabolic and neurologic complications; and in patients with pulmonary edema or acidosis due to low cardiac output.

8 In addition, CLINIMIX E is contraindicated in neonates (less than 28 days of age) receiving concomitant treatment with ceftriaxone, even if separate infusion lines are used, due to the risk of fatal ceftriaxone calcium salt precipitation in the neonate s Vertical Peel Seal CLARITY Dual Chamber Container in 1 L and 2 L sizesINDICATIONSCLINIMIX (amino acids in dextrose) Injections and CLINIMIX E (amino acids with electrolytes in dextrose with calcium) Injections are indicated as a source of calories and protein (and electrolytes for CLINIMIX E) for patients requiring parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated. CLINIMIX and CLINIMIX E may be used to treat negative nitrogen balance in patients. IMPORTANT RISK INFORMATION CLINIMIX and CLINIMIX E Injections are contraindicated in patients with known hypersensitivity to one or more amino acids or dextrose; in patients with inborn errors of amino acid metabolism due to risk of severe metabolic and neurologic complications; and in patients with pulmonary edema or acidosis due to low cardiac output.

9 In addition, CLINIMIX E is contraindicated in neonates (less than 28 days of age) receiving concomitant treatment with ceftriaxone, even if separate infusion lines are used, due to the risk of fatal ceftriaxone calcium salt precipitation in the neonate s bloodstream. Pulmonary vascular precipitates causing pulmonary vascular emboli and pulmonary distress have been reported in patients receiving parenteral nutrition. Excessive addition of calcium and phosphate increases the risk of the formation of calcium phosphate precipitates. The solution should be inspected for precipitates before admixing, after admixing, and again before administration. If signs of pulmonary distress occur, stop the infusion and initiate a medical evaluation. Precipitation of ceftriaxone-calcium can occur when ceftriaxone is mixed with CLINIMIX E, in the same intravenous administration line. Do not administer ceftriaxone simultaneously with CLINIMIX E via a Y-site.

10 Stop infusion immediately and treat patient accordingly if signs or symptoms of a hypersensitivity reaction develop. Monitor for signs and symptoms of early infections. Refeeding severely undernourished patients may result in refeeding syndrome. thiamine deficiency and fluid retention may also develop. Monitor severely undernourished patients and slowly increase nutrient intakes. CLINIMIX and CLINIMIX E solutions containing more than 5% dextrose have an osmolarity of 900 mOsm/L and must be infused through a central catheter. CLINIMIX and CLINIMIX E contain no more than 25 mcg/L of aluminum which may reach toxic levels with prolonged administration in patients with renal impairment. Preterm infants are at greater risk because their kidneys are immature, and they require large amounts of calcium and phosphate solutions which contain aluminum. Patients with renal impairment, including preterm infants, who receive parenteral levels of aluminum at greater than 4 to 5 mcg/kg/day, accumulate aluminum at levels associated with central nervous system and bone toxicity.


Related search queries